MedPath

MIMARK DIAGNOSTICS S.L.

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations

Recruiting
Conditions
Endometrial Cancer
First Posted Date
2025-08-29
Last Posted Date
2025-08-29
Lead Sponsor
MiMARK Diagnostics, S.L.
Target Recruit Count
3000
Registration Number
NCT07148154
Locations
🇪🇸

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain

🇪🇸

Hospital Universitari Campus Vall d'Hebron, Barcelona, Spain

Development of a Molecular Diagnostic Tool for Endometrial Cancer.

Completed
Conditions
Endometrium Cancer
First Posted Date
2024-01-05
Last Posted Date
2025-08-28
Lead Sponsor
MiMARK Diagnostics, S.L.
Target Recruit Count
1950
Registration Number
NCT06192017
Locations
🇪🇸

Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain

🇪🇸

Hospital Dexeus - Quirón de Barcelona, Barcelona, Barcelona, Spain

🇪🇸

Hospital Universitario de Igualada, Igualada, Barcelona, Spain

and more 23 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.